Related Experiment Video
Updated: Nov 16, 2025

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
A stapled peptide mimetic of the CtIP tetramerization motif interferes with double-strand break repair and
Anika Kuster1, Nour L Mozaffari1, Oliver J Wilkinson2
1Institute of Molecular Cancer Research, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Abstract:
Cancer cells display high levels of DNA damage and replication stress, vulnerabilities that could be exploited by drugs targeting DNA repair proteins. Human CtIP promotes homology-mediated repair of DNA double-strand breaks (DSBs) and protects stalled replication forks from nucleolytic degradation, thus representing an attractive candidate for targeted cancer therapy. Here, we establish a peptide mimetic of the CtIP tetramerization motif that inhibits CtIP activity. The hydrocarbon-stapled peptide encompassing amino acid residues 18 to 28 of CtIP (SP18-28) stably binds to CtIP tetramers in vitro and facilitates their aggregation into higher-order structures. Efficient intracellular uptake of SP18-28 abrogates CtIP localization to damaged chromatin, impairs DSB repair, and triggers extensive fork degradation. Moreover, prolonged SP18-28 treatment causes hypersensitivity to DNA-damaging agents and selectively reduces the viability of BRCA1-mutated cancer cell lines. Together, our data provide a basis for the future development of CtIP-targeting compounds with the potential to treat patients with cancer.
Insights
Researchers developed a peptide inhibitor (SP18-28) targeting CtIP, a DNA repair protein. This peptide disrupts DNA repair and selectively kills BRCA1-mutated cancer cells, offering a potential new cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Cancer cells exhibit high DNA damage and replication stress.
- DNA repair proteins like CtIP are potential therapeutic targets.
- CtIP is crucial for DNA double-strand break repair and replication fork stability.
Purpose of the Study:
- To develop a peptide mimetic inhibiting CtIP activity.
- To investigate the therapeutic potential of targeting CtIP in cancer.
Main Methods:
- Creation of a hydrocarbon-stapled peptide (SP18-28) mimicking the CtIP tetramerization motif.
- In vitro binding assays and assessment of CtIP tetramer aggregation.
- Evaluation of intracellular uptake, chromatin localization, DNA repair, and replication fork stability.
- Testing sensitivity to DNA-damaging agents and cancer cell viability assays, including BRCA1-mutated lines.
Main Results:
- SP18-28 binds CtIP tetramers and induces aggregation.
- SP18-28 treatment impairs CtIP's role in DNA repair and causes replication fork degradation.
- SP18-28 treatment increases sensitivity to DNA-damaging agents.
- SP18-28 selectively reduces viability in BRCA1-mutated cancer cells.
Conclusions:
- SP18-28 effectively inhibits CtIP function in cancer cells.
- Targeting CtIP with peptide mimetics shows promise for cancer therapy.
- This approach may be particularly effective for BRCA1-mutated cancers.
Related Concept Videos
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Homologous Recombination
Drugs that Destabilize Microtubules

